Fonar [FONR] vs Thermo Fisher [TMO] Detailed Stock Comparison

Fonar Corporation

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Fonar Corporation wins in 8 metrics, Thermo Fisher Scientific Inc. wins in 11 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Fonar Corporation Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) 16.35 25.84 Fonar Corporation
Price-to-Book Ratio 0.70 3.31 Fonar Corporation
Debt-to-Equity Ratio 24.44 82.91 Fonar Corporation
PEG Ratio 2.37 2.29 Thermo Fisher Scientific Inc.
EV/EBITDA 6.37 19.02 Fonar Corporation
Profit Margin (TTM) 7.13% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) 11.74% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) 11.74% 17.89% Thermo Fisher Scientific Inc.
Return on Equity 6.01% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) 3.16% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $7.45M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 31.72% 22.27% Fonar Corporation
Price-to-Sales Ratio (TTM) 1.12 3.86 Fonar Corporation
Enterprise Value $95.88M $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 0.90 4.75 Fonar Corporation
Gross Profit Margin (TTM) 37.95% N/A N/A
Revenue per Share (TTM) $16 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $1.15 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 0.99 0.97 Thermo Fisher Scientific Inc.
Short % of Float 1.18% 1.22% Fonar Corporation

Fonar Corporation vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

FONR
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fonar Corporation-0.10%0.95%0.90%2.86%32.66%3.08%
Thermo Fisher Scientific Inc.-1.69%3.89%2.45%-6.72%-18.35%-20.01%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fonar Corporation31.72%13.49%5.18%16.25%827.18%55.92%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: Fonar Corporation vs Thermo Fisher Scientific Inc.

MetricFONRTMO
Market Information
Market Cap i$118.64M$174.55B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i51,8962,356,220
90 Day Avg. Volume i47,2952,071,517
Last Close$19.09$473.95
52 Week Range$13.62 - $19.16$385.46 - $643.99
% from 52W High-0.37%-26.40%
All-Time High$310.00 (Dec 06, 1982)$672.34 (Dec 27, 2021)
% from All-Time High-93.84%-29.51%
Growth Metrics
Quarterly Revenue Growth0.02%0.06%
Quarterly Earnings Growth0.05%0.10%
Financial Health
Profit Margin (TTM) i0.07%0.15%
Operating Margin (TTM) i0.12%0.18%
Return on Equity (TTM) i0.06%0.14%
Debt to Equity (MRQ) i24.4482.91
Cash & Liquidity
Book Value per Share (MRQ)$27.01$141.96
Cash per Share (MRQ)$8.10$8.75
Operating Cash Flow (TTM) i$9.23M$8.29B
Levered Free Cash Flow (TTM) i$2.44M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend i$0.00$1.76

Valuation & Enterprise Metrics Analysis: Fonar Corporation vs Thermo Fisher Scientific Inc.

MetricFONR (Apr 24, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i16.3525.84
Forward P/E iN/A17.16
PEG Ratio i2.372.29
Price to Sales (TTM) i1.123.86
Price to Book (MRQ) i0.703.31
Market Capitalization
Market Capitalization i$118.64M$174.55B
Enterprise Value i$95.88M$214.76B
Enterprise Value Metrics
Enterprise to Revenue i0.904.75
Enterprise to EBITDA i6.3719.02
Risk & Other Metrics
Beta i0.990.97
Book Value per Share (MRQ) i$27.01$141.96

Financial Statements Comparison: Fonar Corporation vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFONR (2025)TMO (2025)
Revenue/Sales i104.35M44.56B
Cost of Goods Sold i61.44M26.32B
COGS % of Revenue i58.9%59.1%
Gross Profit i42.91M18.24B
Gross Margin i41.1%40.9%
Research & Development i1.58M1.40B
Operating Income (EBIT) i11.60M8.11B
Operating Margin i11.1%18.2%
EBITDA i16.33M11.86B
EBITDA Margin i15.7%26.6%
Pre-Tax Income i13.78M7.31B
Pre-Tax Income % of Revenue i13.2%16.4%
Income Tax i3.11M547.00M
Income Tax % of Revenue i3.0%1.2%
Net Income (Profit) i10.67M6.72B
Profit Margin i10.2%15.1%

Balance Sheet & Liquidity Metrics

MetricFONR (2025)TMO (2025)
Cash & Equivalents i56.33M9.85B
Total Current Assets i144.67M28.71B
Total Current Assets % of Revenue i138.6%64.4%
Total Current Liabilities i17.12M15.19B
Total Current Liabilities % of Revenue i16.4%34.1%
Long-Term Debt i35.29M35.85B
Long-Term Debt % of Revenue i33.8%80.5%
Total Shareholders Equity i160.10M53.54B
Retained Earnings i-5.29M59.16B
Retained Earnings % of Revenue i-5.1%132.8%
Property, Plant & Equipment i77.28M0

Cash Flow Statement Comparison

MetricFONR (2025)TMO (2025)
Operating Cash Flow i9.20M7.82B
Operating Cash Flow % of Revenue i8.8%17.5%
Capital Expenditures i-3.79M-1.48B
Free Cash Flow i7.45M6.29B
FCF Margin i7.1%14.1%
Debt Repayment i-113,940-3.51B
Common Stock Repurchase i-1.81M-3.00B

Short Interest & Institutional Ownership Analysis

MetricFONRTMO
Shares Short i70,9614.54M
Short Ratio i1.332.38
Short % of Float i1.18%1.22%
Shares Outstanding i6.30M371.62M
Float Shares i5.13M371.07M
% Held by Insiders i12.28%0.17%
% Held by Institutions i45.39%95.23%
% Held by Public i42.33%4.60%

Dividend Analysis & Yield Comparison: Fonar Corporation vs Thermo Fisher Scientific Inc.

MetricFONRTMO
Last 12-Month Dividend i$0.00$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend i$0.00$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends i$0.00$4.80
Ex-Dividend DateN/AMar 13, 2026